β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged to be one of the most important pathogens both in health care and in community-onset infections. Daptomycin (DAP) is a cyclic anionic lipopeptide recommended for treatment of skin infections, bacteremia, and right-sided endocarditis caused by MRSA. Resistance to DAP (DAP r ) has been reported in MRSA and is mostly accompanied by a parallel decrease in oxacillin resistance, a process known as the “seesaw effect.” Our study provides evidence that the seesaw effect applies to other β-lactams and carbapenems of clinical use, including nafcillin (NAF), cefotaxime (CTX), amoxicillin-clavulanic (AMC), and imipenem (IMP), in heterogeneous DAP r MRSA strains but not in MRSA strains expressing homogeneous β-lactam resistance. The antibacterial efficacy of DAP in combination with β-lactams was evaluated in isogenic DAP-susceptible (DAP s )/Dap r MRSA strains originally obtained from patients that failed DAP monotherapy. Both in vitro (MIC, synergy-kill curve) and in vivo (wax worm model) approaches were used. In these models, DAP and a β-lactam proved to be highly synergistic against both heterogeneous and homogeneous clinical DAP r MRSA strains. Mechanistically, β-lactams induced a reduction in the cell net positive surface charge, reverting the increased repulsion provoked by DAP alone, an effect that may favor the binding of DAP to the cell surface. The ease of in vitro mutant selection was observed when DAP s MRSA strains were exposed to DAP. Importantly, the combination of DAP and a β-lactam prevented the selection of DAP r variants. In summary, our data show that the DAP–β-lactam combination may significantly enhance both the in vitro and in vivo efficacy of anti-MRSA therapeutic options against DAP r MRSA infections and represent an option in preventing DAP r selection in persistent or refractory MRSA infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus
Bannerman, T. L., Hancock, G. A., Tenover, F. C., & Miller, J. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.551-555.1995 · Cited by 550
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Natural products to drugs: daptomycin and related lipopeptide antibiotics
Baltz, R. H., Miao, V., & Wrigley, S. K. (2005) · Natural Product Reports · doi:10.1039/b416648p · Cited by 393
Research works printed but not linked: 1
- NCCLS/CLSI. 2007. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8, 8th ed. NCCLS/CLSI, Wayne, PA.
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
A Current Perspective on Daptomycin for the Clinical Microbiologist
Humphries, R. M., Pollett, S., & Sakoulas, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-13 · Cited by 240
Mechanisms of drug resistance: daptomycin resistance
Tran, T. T., Munita, J. M., & Arias, C. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12948 · Cited by 234
Argenson, J., Arndt, M., Babis, G. C., Battenberg, A. K., Budhiparama, N. C., Catani, F., Chen, F., de Beaubien, B. C., Ebied, A. M., Esposito, S., et al. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.09.025 · Cited by 204
Sakoulas, G., Moise, P. A., Casapao, A. M., Nonejuie, P., Olson, J., Okumura, C. Y. M., Rybak, M. J., Kullar, R., Dhand, A., Rose, W. E., et al. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.05.061 · Cited by 181
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
Thabit, A. K., Crandon, J. L., & Nicolau, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.993381 · Cited by 160
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
Sakoulas, G., Okumura, C. Y. M., Thienphrapa, W., Olson, J., Nonejuie, P., Dam, Q., Dhand, A., Pogliano, J., Yeaman, M. R., Hensler, M. E., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1100-7 · Cited by 153
Native valve right sided infective endocarditis
Akinosoglou, K., Apostolakis, E. E., Marangos, M. N., & Pasvol, G. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.01.010 · Cited by 137
Purrello, S., Garau, J., Giamarellos‐Bourboulis, E. J., Mazzei, T., Pea, F., Soriano, À., & Stefani, S. (2016) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.07.010 · Cited by 128
β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium
Fisher, J. F., & Mobashery, S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01010 · Cited by 124
Radlinski, L. C., Rowe, S. E., Brzozowski, R., Wilkinson, A. D., Huang, R., Eswara, P. J., & Conlon, B. P. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.07.009 · Cited by 123
What’s new in multidrug-resistant pathogens in the ICU?
Zilahi, G., Artigas, A., & Martín‐Loeches, I. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0199-4 · Cited by 118
Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
Foster, T. J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.06.005 · Cited by 117
Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
van Hal, S. J., Tong, S. Y. C., & Davis, J. S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1396906 · Cited by 118
Stefani, S., Campanile, F., Santagati, M., Mezzatesta, M. L., Cafiso, V., & Pacini, G. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.05.008 · Cited by 109
Jorgensen, S. C. J., Zasowski, E. J., Trinh, T. D., Lagnf, A. M., Bhatia, S., Sabagha, N., Abdul‐Mutakabbir, J. C., Alosaimy, S., Mynatt, R. P., Davis, S. L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz746 · Cited by 105
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
Hamed, K. A., González-Ruiz, A., & Seaton, A. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s99046 · Cited by 104
Adeniji, O. O., Nontongana, N., Okoh, J. C., & Okoh, A. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315038 · Cited by 101
McCreary, E. K., Kullar, R., Geriak, M., Zasowski, E. J., Rizvi, K., Schulz, L. T., Ouellette, K., Vasina, L., Haddad, F. A., Rybak, M. J., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz538 · Cited by 98
Moise, P. A., Amodio-Groton, M. I., Rashid, M., Lamp, K. C., Hoffman-Roberts, H., Sakoulas, G., Yoon, M., Schweitzer, S., & Rastogi, A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02192-12 · Cited by 97
Daptomycin: The role of high-dose and combination therapy for Gram-positive infections
Gould, I. M., Miró, J. M., & Rybak, M. J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.05.005 · Cited by 93
Bal, A. M., David, M. Z., Garau, J., Gottlieb, T., Mazzei, T., Scaglione, F., Tattevin, P., & Gould, I. M. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.05.019 · Cited by 92
Berti, A. D., Sakoulas, G., Nizet, V., Tewhey, R., & Rose, W. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00594-13 · Cited by 87
Dhand, A., & Sakoulas, G. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.005 · Cited by 80
Gudiol, F., Aguado, J. M., Almirante, B., Bouza, E., Cercenado, E., Domínguez, M. Á., Gasch, O., Lora-Tamayo, J., Miró, J. M., Palomar, M., et al. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.03.015 · Cited by 78
Tong, S. Y. C., Nelson, J., Paterson, D. L., Fowler, V. G., Howden, B. P., Cheng, A. C., Chatfield, M. D., Lipman, J., van Hal, S., O'Sullivan, M. V. N., et al. (2016) · Trials · doi:10.1186/s13063-016-1295-3 · Cited by 77
When sepsis persists: a review of MRSA bacteraemia salvage therapy
Kullar, R., Sakoulas, G., Deresinski, S. C., & van Hal, S. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv368 · Cited by 76
Zarenezhad, E., Abdulabbas, H. T., Marzi, M., Ghazy, E., Ekrahi, M., Pezeshki, B., Ghasemian, A., & Moawad, A. A. (2022) · Antibiotics · doi:10.3390/antibiotics11091208 · Cited by 71
Berti, A. D., Theisen, E., Sauer, J., Nonejuie, P., Olson, J., Pogliano, J., Sakoulas, G., Nizet, V., Proctor, R. A., & Rose, W. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02071-15 · Cited by 70
Ceftobiprole: drug evaluation and place in therapy
Giacobbe, D. R., Rosa, F. G. D., Bono, V. D., Grossi, P., Pea, F., Petrosillo, N., Rossolini, G. M., Tascini, C., Tumbarello, M., Viale, P., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1667229 · Cited by 70
Ortwine, J. K., Werth, B. J., Sakoulas, G., & Rybak, M. J. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2013.10.002 · Cited by 70
Romero-Urbina, D. G., Lara, H. H., Velázquez-Salazar, J. J., Arellano-Jiménez, M. J., Larios, E., Srinivasan, A., Lopez-Ribot, J. L., & Yacamán, M. J. (2015) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.6.246 · Cited by 68
Renzoni, A., Kelley, W. L., Rosato, R. R., Martínez, M. P. S., Roch, M., Fatouraei, M., Haeusser, D. P., Margolin, W., Fenn, S. J., Turner, R. D., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01634-16 · Cited by 66
Self-citationSader, H. S., Flamm, R. K., & Jones, R. N. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.01.001 · Cited by 63
Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia
Gudiol, C., Cuervo, G., Shaw, E., Pujol, M., & Carratalà, J. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1403585 · Cited by 63
Song, Y., Rubio, A., Jayaswal, R. K., Silverman, J. A., & Wilkinson, B. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058469 · Cited by 61
Teethaisong, Y., Autarkool, N., Sirichaiwetchakoon, K., Krubphachaya, P., Kupittayanant, S., & Eumkeb, G. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0090-2 · Cited by 61
Development of a monoclonal antibody-based immunochromatographic strip for cephalexin
Guo, J., Liu, L., Xue, F., Xing, C., Song, S., Kuang, H., & Xu, C. (2014) · Food and Agricultural Immunology · doi:10.1080/09540105.2014.907242 · Cited by 61
Werth, B. J., Barber, K. E., Ireland, C. E., & Rybak, M. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00088-14 · Cited by 56
Treatment of Infections Due to Resistant Staphylococcus aureus
Anstead, G. M., Cadena, J., & Javeri, H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_16 · Cited by 52
Sader, H. S., Flamm, R. K., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00484-13 · Cited by 52
Bartash, R. M., & Nori, P. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.07.019 · Cited by 49
Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics?
Brunel, A.-S., & Guery, B. P. (2017) · Swiss Medical Weekly · doi:10.4414/smw.2017.14553 · Cited by 47
Shaw, E., Miró, J. M., Puig‐Asensio, M., Pigrau, C., Barcenilla, F., Murillas, J., García‐Pardo, G., Espejo, E., Padilla, B., García‐Reyne, A., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006723 · Cited by 46
Hines, K. M., Shen, T., Ashford, N. K., Waalkes, A., Penewit, K. M., Holmes, E. A., McLean, K., Salipante, S. J., Werth, B. J., & Xu, L. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz562 · Cited by 44
A review of current treatment strategies for infective endocarditis
Paz, D. L., Lakbar, I., & Tattevin, P. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822165 · Cited by 44
Plata, K. B., Riosa, S., Singh, C. R., Rosato, R. R., & Rosato, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061083 · Cited by 41
Self-citationSnyder, A. D. H., Werth, B. J., Nonejuie, P., McRoberts, J. P., Pogliano, J., Sakoulas, G., Yim, J., Singh, N. B., & Rybak, M. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00687-16 · Cited by 41
Falcone, M., Russo, A., & Venditti, M. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.02.012 · Cited by 42
Chen, F.-J., Lauderdale, T.-L., Lee, C.-H., Hsu, Y.-C., Huang, I.-W., Hsu, P.-C., & Yang, C.-S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01086 · Cited by 40
Timbrook, T. T., Caffrey, A. R., Luther, M. K., Lopes, V., & LaPlante, K. L. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2070 · Cited by 39
Hornak, J. P., Anjum, S. H., & Reynoso, D. (2019) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936119886504 · Cited by 39
Nigo, M., Díaz, L., Carvajal, L. P., Tran, T. T., Ríos, R., Panesso, D., Garavito, J. D., Miller, W. R., Wanger, A. R., Weinstock, G. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01235-16 · Cited by 39
Ortwine, J. K., & Bhavan, K. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1435128 · Cited by 38
Claeys, K. C., Smith, J. R., Casapao, A. M., Mynatt, R. P., Avery, L. M., Shroff, A., Yamamura, D. L. R., Davis, S. L., & Rybak, M. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04141-14 · Cited by 37
Berti, A. D., Baines, S. L., Howden, B. P., Sakoulas, G., Nizet, V., Proctor, R. A., & Rose, W. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04990-14 · Cited by 37
Taglialegna, A., Varela, M. C., Rosato, R. R., & Rosato, A. E. (2019) · mSphere · doi:10.1128/msphere.00557-18 · Cited by 37
Self-citationPalacios, L., Rosado, H., Micol, V., Rosato, A. E., Bernal, P., Arroyo, R., Grounds, H., Anderson, J. C., Stabler, R. A., & Taylor, P. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093830 · Cited by 34
Self-citationZheng, X., Berti, A. D., McCrone, S., Roch, M., Rosato, A. E., Rose, W. E., & Chen, B. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02100-17 · Cited by 34
Self-citationAkins, R. L., Katz, B. D., Monahan, C., & Alexander, D. C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04219-14 · Cited by 34
Molina, K. C., Morrisette, T., Miller, M. A., Huang, V., & Fish, D. N. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00468-20 · Cited by 32
Aprile, I. G., Bordieri, C., Gilardi, A., Milazzo, M. L., Russo, G., Santis, F. D., Frusciante, R., Iannaccone, E., Erra, C., Ricci, E., et al. (2013) · PubMed · Cited by 31
Lenhard, J. R., von Eiff, C., Hong, I. S., Holden, P. N., Bear, M. D., Suen, A., Bulman, Z. P., & Tsuji, B. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04508-14 · Cited by 31
Principles of Anti-Infective Therapy
Eliopoulos, G. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00287-6 · Cited by 31
Murray, B. E., Arias, C. A., & Nannini, E. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00030-8 · Cited by 28
Combination of Vancomycin or Daptomycin and Beta‐lactam Antibiotics: A Meta‐analysis
Kale-Pradhan, P. B., Giuliano, C. A., Jongekrijg, A., & Rybak, M. J. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2437 · Cited by 27
Fernandez, R., Paz, L. I., Rosato, R. R., & Rosato, A. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03019-14 · Cited by 26
Self-citationYim, J., Smith, J. R., Singh, N. B., Rice, S., Stamper, K. C., de la Mària, C. G., Bayer, A. S., Mishra, N. N., Miró, J. M., Tran, T. T., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx130 · Cited by 25
Nichols, C., Wardlow, L. C., Coe, K. E., & Sobhanie, M. M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab327 · Cited by 26
Roch, M., Varela, M. C., Taglialegna, A., & Rosato, A. E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz418 · Cited by 25
Self-citationPericàs, J. M., Nathavitharana, R. R., García-de-la-Mària, C., Falces, C., Ambrosioni, J., Almela, M., García‐González, J., Quintana, E., Marco, F., Moreno, A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00516-19 · Cited by 24
Jiang, S., Zhuang, H., Zhu, F., Xiang, W. D., Zhang, J., Sun, L., Ji, S., Wang, H., Wu, D., Zhao, F., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01295-21 · Cited by 23
Bal, A. M., Garau, J., Gould, I. M., Liao, C., Mazzei, T., Nimmo, G. R., Soriano, À., Stefani, S., & Tenover, F. C. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.01.002 · Cited by 23
Boyle, K. K., Kuo, F., Horcajada, J. P., Hughes, H. C., Cavagnaro, L., Marculescu, C. E., McLaren, A. C., Nodzo, S. R., Riccio, G., Sendi, P., et al. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.09.074 · Cited by 23
Guleri, A., Utili, R., Dohmen, P. M., Petrosillo, N., Piper, C., Pathan, R. B., & Hamed, K. A. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0075-9 · Cited by 23
Liu, Y., Chen, X., Li, Z., Xu, W., Tao, W., Wu, J., Yang, J., Deng, Z., & Sun, Y. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00467 · Cited by 21
Chambers, H. F. “., Basuino, L., Hamilton, S. M., Choo, E. J., & Moise, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00589-16 · Cited by 20
Li, B., Kang, W. C. M., Liu, H., Wang, Y., Yu, C., Zhu, X., Dou, J., Cai, H., & Zhou, C. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0769-x · Cited by 20
Zhang, R., Beltran, I. A. B., Ashford, N. K., Penewit, K. M., Waalkes, A., Holmes, E. A., Hines, K. M., Salipante, S. J., Xu, L., & Werth, B. J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.688357 · Cited by 20
Daptomycin Use in Children: Experience With Various Types of Infection and Age Groups
Syrogiannopoulos, G. A., Michoula, A. N., Petinaki, E., & Grivea, I. N. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001629 · Cited by 20
Yi, Y.-H., Wang, J., Yin, W., & Xu, W. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0350 · Cited by 19
Smith, J. R., Arya, A., Yim, J., Barber, K. E., Hallesy, J. A., Singh, N. B., & Rybak, M. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01666-15 · Cited by 19
Crawford, C. L., Dalecki, A. G., Perez, M. D., Schaaf, K., Wolschendorf, F., & Kutsch, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-65978-y · Cited by 19
Martins, F. S., Martins, J. E. S., Severino, P. B., Annaert, P., & Sy, S. K. B. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15731 · Cited by 18
Staphylococcus aureus : a model for bacterial cell biology and pathogenesis
Pinho, M. G., Götz, F., & Peschel, A. (2025) · Journal of Bacteriology · doi:10.1128/jb.00106-25 · Cited by 18
A comprehensive review of advanced strategies to combat antimicrobial resistance
Behera, B., Singh, R. P., Sharma, K., Rai, A., Singh, S., & Balan, B. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04464-3 · Cited by 18
Jenson, R. E., Baines, S. L., Howden, B. P., Mishra, N. N., Farah, S., Lew, C. I., Berti, A. D., Shukla, S. K., Bayer, A. S., & Rose, W. E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00890-20 · Cited by 18
Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review
Antonello, R. M., Canetti, D., & Riccardi, N. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac346 · Cited by 17
Abdul‐Mutakabbir, J. C., Kebriaei, R., Stamper, K. C., Sheikh, Z., Maassen, P. T., Lev, K. L., & Rybak, M. J. (2020) · Antibiotics · doi:10.3390/antibiotics9100696 · Cited by 14
Cunha, B. A., & Gran, A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.04.006 · Cited by 14
Gagetti, P. S., Pasterán, F. G., Martínez, M. P. S., Fatouraei, M., Gu, J., Fernandez, R., Paz, L., Rose, W. E., Corso, A. C., & Rosato, A. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00168-16 · Cited by 14
Self-citationde Carvalho, C. C. C. R., Taglialegna, A., & Rosato, A. E. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab356 · Cited by 13
Self-citationZapata, B., Alvarez, D. N., Farah, S., García-de-la-Maria, C., Miró, J. M., Sakoulas, G., Bayer, A. S., & Mishra, N. N. (2018) · Current Microbiology · doi:10.1007/s00284-018-1491-3 · Cited by 12
Pee, C. J. E., Pader, V., Ledger, E. V. K., & Edwards, A. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02105-18 · Cited by 12
Roch, M., Varela, M. C., Taglialegna, A., Rose, W. E., & Rosato, A. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00956-18 · Cited by 11
Self-citationMacrolide, lincosamide, glycopeptide, and other antibacterial antibiotics
Qian, Y., Mobashery, S., & Fisher, J. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90575-6.00008-9 · Cited by 10
Does vancomycin have a future in the treatment of skin infections?
O’Brien, D. J., & Gould, I. M. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000048 · Cited by 10
In-vitro activity of ceftriaxone combined with newer agents against MRSA
Aktaş, G. (2016) · Journal of Chemotherapy · doi:10.1080/1120009x.2016.1246633 · Cited by 10
Metadata
- Authors
- Mehta, S., Singh, C., Plata, K. B., Chanda, P. K., Paul, A., Riosa, S., Rosato, R. R., & Rosato, A. E.
- Affiliations
- Houston Methodist Research Institute (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-12
- Volume
- 56
- Issue
- 12
- Pages
- 6192-6200
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3497165
- OpenAlex
- W2146598854
- Cited by
- 142
- References
- 49
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 9 · 2019: 11 · 2018: 14 · 2017: 11 · 2016: 13 · 2015: 20 · 2014: 12 · 2013: 15 · 2012: 2
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI080688)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- daptomycin, methicillin-resistant Staphylococcus aureus, beta-lactam antibiotics, carbapenems, combination therapy, drug synergy, daptomycin resistance, seesaw effect, oxacillin resistance, nafcillin, cefotaxime, imipenem, mutant selection, cell surface charge, MRSA skin infection
- MeSH terms
- Animals, Anti-Bacterial Agents, Cefotaxime, DNA, Drug Synergism, Insecta, Larva, Microbial Sensitivity Tests, Mutation, Nafcillin, Oxacillin, Staphylococcal Infections, Imipenem, Daptomycin, Amoxicillin-Potassium Clavulanate Combination, Drug Resistance, Bacterial, beta-Lactams, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.